Coimmunization with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H5N1 vaccine against heterologous virus.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Veterinary Microbiology

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vetmic.2017.03.004PMID 28619136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice.

  2016cited by this paper
• Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant

  2015cited by this paper
• H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virus.

  2015cited by this paper
• Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.

  2015cited by this paper
• Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.

  2014cited by this paper
• Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.

  2014cited by this paper
• Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.

  2014cited by this paper
• Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant.

  2013cited by this paper
• Induction of robust immunity response in mice by dual-expression-system-based recombinant baculovirus expressing the capsid protein of porcine circovirus type 2

  2013cited by this paper
• In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.

  2012cited by this paper
• Vaccination with Different M2e Epitope Densities Confers Partial Protection against H5N1 Influenza A Virus Challenge in Chickens

  2011cited by this paper
• Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt

  2011cited by this paper
• Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain

  2010cited by this paper
• Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

  2010cited by this paper
• Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

  2010cited by this paper
• Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus

  2010cited by this paper
• Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?

  2009cited by this paper
• A universal epitope-based influenza vaccine and its efficacy against H5N1.

  2009cited by this paper
• M2e-based universal influenza A vaccine.

  2009cited by this paper
• Scientific barriers to developing vaccines against avian influenza viruses

  2007cited by this paper
• Baculovirus-Mediated Gene Expression in Chicken Primary Cells

  2006cited by this paper
• Cell-mediated Protection in Influenza Infection

  2006cited by this paper
• Involvement of the Toll-Like Receptor 9 Signaling Pathway in the Induction of Innate Immunity by Baculovirus

  2005cited by this paper
• Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.

  2005cited by this paper
• Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity

  2004cited by this paper
• Epitope-based vaccines: an update on epitope identification, vaccine design and delivery.

  2003cited by this paper
• Baculovirus Induces an Innate Immune Response and Confers Protection from Lethal Influenza Virus Infection in Mice1

  2003cited by this paper
• Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus.

  2002cited by this paper
• Roles of alpha beta and gamma delta T cell subsets in viral immunity.

  1992cited by this paper
• Baculovirus expression vectors: a laboratory manual.

  1992cited by this paper
• Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells.

  1989cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper
• Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Novel Variants of Clade 2.3.4 Highly Pathogenic Avian Influenza A(h5n1) Viruses, China

  year unknowncited by this paper

• A self-assembled protein nanocage as a universal influenza vaccine induces enhanced broadly cross-reactive immunity.

  2026cites this paper
• M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challenge

  2024influential citation
• Construction with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H9N2 vaccine against heterologous virus.

  2024cites this paper
• Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy

  2022cites this paper
• Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens

  2022cites this paper
• Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens

  2021cites this paper
• Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.

  2019cites this paper
• A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.

  2018cites this paper